ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 267461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 267461; 2) Community: the network communities that were significantly associated with the response to NSC 267461; 3) Molecule: the relationships between components within communities and NSC 267461; 4) MDR: the compounds that were significantly associated with the NSC 267461.

NSC Compound Enrichment Correlation
NSC 639504 Cyclopentanone, 2-[(dimethylamino)methyl]-5-octylidene-, hydrochloride 0.000284051704014449 0.68116733
NSC 656599 Null 0.000284051704014449 0.78974015
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.000284051704014449 -0.12390331
NSC 368697 Benz[a]anthracene-1,7,12(12b-H)-trione, 2,3,4,4a-tetra- hydro-2,3,4a,8,12a-pentahydroxy-3-methyl- 0.000374267341249424 0.80982728
NSC 677240 Null 0.000374267341249424 0.59684482
NSC 677249 Null 0.000374267341249424 0.53787393
NSC 682995 5,8-Quinolinedione, 2-methyl- 0.000374267341249424 0.69872018
NSC 100046 Elephantopin 0.000395532514722381 0.67840156
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.000395532514722381 0.73893979
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.000395532514722381 0.61286776
Total:101  Current:3    [First] [Prev] [Next] [Last]